gamma-glutamylcysteine has been researched along with Acute Confusional Senile Dementia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, A; Chen, L; Luo, L; Wang, Y; Yin, Z | 1 |
| Braidy, N; Bridge, W; Chen, Z; Li, B; Liu, Y; Sachdev, P; Welch, J; Yao, H; Zarka, M | 1 |
| Butterfield, DA; Pocernich, CB | 1 |
1 review(s) available for gamma-glutamylcysteine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Elevation of glutathione as a therapeutic strategy in Alzheimer disease.
Topics: Acetylcysteine; Alzheimer Disease; Antioxidants; Dipeptides; DNA; Glutathione; Humans; Oxidation-Reduction | 2012 |
2 other study(ies) available for gamma-glutamylcysteine and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
γ-Glutamylcysteine attenuates amyloid-β oligomers-induced neuroinflammation in microglia via blocking NF-κB signaling pathway.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Dipeptides; Inflammation; Mice; Microglia; NF-kappa B; Reactive Oxygen Species; Signal Transduction | 2022 |
Supplementation with γ-glutamylcysteine (γ-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves spatial memory in a murine model of AD.
Topics: Alzheimer Disease; Amyloid; Animals; Dietary Supplements; Dipeptides; Disease Models, Animal; Encephalitis; Male; Mice; Mice, Transgenic; Oxidative Stress; Spatial Memory | 2021 |